Russia Infection Control Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Product (Disinfectants, Sterilization (Low-Temperature Sterilization, Heat Sterilization, Contract Sterilization)), By End User Industry (Healthcare, Food And Beverage, Chemical) - Forecasts From 2022 To 2027

The Russian infection control market is projected to grow at a CAGR of 4.20% over the forecast period. The market is estimated to reach a value of US$396.574 million from US$297.270 million.

There is a lack of awareness and presence of poor hygiene practices in most of the Eurasian countries due to the absence of using evidence-based approaches to medicine and public health, which has increased the number of nosocomial infections, or infections acquired in the hospital. This has resulted in the expansion of training centers and research facilities to combat, which is a burdening situation, due to which AIHA developed an infection control program that was a region-wide and cross-partnership program. The program was in collaboration with Harvard Medical International, Hospital Infection Prevention and Quality Assessment (INQUAL), among some other institutions and healthcare bodies in the year 1997, and continuous improvements were made from the years 2001 to 2004. Thus, the presence of this action is a contributing factor to the market’s growth.

Rise in awareness for the use of proper use of disinfectants and infection control methods.

There is a growing awareness among the population in regard to avoiding the spread of infections by following proper disinfection and infection control methods, which is leading them to demand more advanced and better medical treatment conditions and facilities from healthcare workers, thus urging them to adopt these practices. This is leading to an increased demand for infection control technologies, products, and solutions, and causing a surge in the market’s growth.

Furthermore, product offerings are one of the initiatives that are being taken by the market players, so that they are able to maximize their profits, gain a competitive edge over their rivals, fulfill the ever-rising demand for enhanced infection control products and provide a boost to the market’s growth. For instance, BD, one of the leading medical technology companies that deals in the manufacture and sale of medical devices, instrument systems, and other chemical reagents, and is based in America, offers a range of products under their product portfolio. It offers a product called ChloraPrep, which is a product that shows fast action and is an antiseptic product that was developed to cater to major and minor medical procedures.

The formula of this product consists of 2% chlorhexidine gluconate, and 70% isopropyl alcohol, is effective against different types of bacteria, including the bacteria strain Staphylococcus aureus (MRSA), and provides continuous anti-microbial action for at least 2 days. In addition, it also offers some other products in its portfolio to cater to different applications.

The usage and adoption in the healthcare industry are expected to gain momentum over the forecast period.

The healthcare industry is projected to hold a significant market share and gain momentum over the forecast period. This is majorly attributable to the fact that there is an increasing prevalence and awareness among the middle-aged and older individuals in the population, which is leading to their demanding quality healthcare, and the usage of effective infection control practices to reduce the growing number of cases of HAI’s (hospital-acquired infections).

Key Developments

• March 2020 - The multinational corporation 3M Co. has ceased operations in Russia following its invasion of Ukraine, becoming the newest Western company to do so.
• June 2020 - To prevent President Vladimir Putin from contracting the coronavirus, the Kremlin has set up specialized disinfection tunnels.

Impact of the COVID-19 pandemic

The need for sterilization and disinfection in hospitals and clinics has increased during COVID-19. There have also been technological advances in sterilization and disinfection equipment, a surge in the outsourcing of sterilization services by hospitals, pharmaceutical, and medical device companies, and an increase in the production of single-use products and medical nonwovens. The COVID-19 outbreak has caused a sharp rise in demand for infection control products, which has had a significant impact on the expansion of the infection control market in Russia. The market for infection control is likely to rise, but it will be constrained by the negative effects of chemical disinfectants and worries about the safety of reprocessed devices. On the other hand, during the forecast period, increased use of single-use medical nonwovens and devices is anticipated to present profitable prospects.

Segmentation

• By Product
  • Disinfectants
  • Sterilization
    • Low-Temperature Sterilization
    • Heat Sterilization
    • Contract Sterilization
• By End User Industry
  • Healthcare
  • Food and Beverage
  • Chemical

---